HIV Infection

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA approval · 2006-06-23
FDA Approved: PREZISTA — Original Application (Janssen Products LP)
The FDA approves Prezista (darunavir) under an original application by Janssen Products LP for the treatment of HIV-1 infection; this marks …
FDA approval · 2006-06-13
FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for Epivir (lamivudine) submitted by ViiV Healthcare Company. This action represents a supplemental …
FDA approval · 2006-06-13
FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for EPIVIR (lamivudine) submitted by ViiV Healthcare Company. Lamivudine is used to treat HIV-1 infe…
CLINICAL_TRIALS trial_result · 2006-06-09
Clinical Trial Update: Pravastatin for Hyperlipidaemia in HIV. [Phase 4]
A Phase 4 clinical trial evaluating pravastatin for hyperlipidemia in HIV-infected individuals has completed.
CLINICAL_TRIALS trial_result · 2006-06-07
Clinical Trial Update: Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding [Phase 2]
A Phase 2 randomized trial evaluated whether suppressive therapy for genital herpes affects HIV shedding.
Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
CLINICAL_TRIALS trial_result · 2006-06-02
Clinical Trial Update: A Study to Assess the Pharmacokinetics of Dapivirine (TMC120) Vaginal Microbicide Gel [Phase 1]
Phase 1 pharmacokinetic study of dapivirine vaginal microbicide gel (TMC120) is completed. The trial was sponsored by the International Part…
CLINICAL_TRIALS trial_result · 2006-05-24
Clinical Trial Update: Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIV [Phase 4]
A Phase 4 clinical trial evaluating the influence of vaccination on HIV viral load and immunologic responses has completed.
FDA approval · 2006-05-10
FDA Approved: RETROVIR — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for Retrovir (zidovudine) submitted by ViiV Healthcare Company.
CLINICAL_TRIALS trial_result · 2006-05-10
Clinical Trial Update: Structured Treatment Interruptions in Chronic HIV Infection [Phase 3]
Completed Phase 3 trial evaluating structured treatment interruptions in chronic HIV infection.